Isophosphamide
-
-
CAS No:
3778-73-2
-
Formula:
C7H15Cl2N2O2P
-
Synonyms:
IF;Ifex;cyfos;z4942;A-4942;holoxan;mjf9325;IfoMide;NSC-1097;mitoxana
-
China Export:
From 2018.11 to 2019.11, total export volume of Isophosphamide from China was 64,534,318KG while total export value was $1,953,812,763. The biggest proportion of exporting volume in the last 12 months was 11.30% in 2019.03.
- Categories:
Request for Quotation -
CAS No:
Description
Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors.
Basic Attributes
-
3778-73-2
-
C7H15Cl2N2O2P
-
261.09
-
260.024811
-
41.6
-
0.9
-
223-237-3
-
HOMGKSMUEGBAAB-UHFFFAOYSA-N
-
4
-
1
-
5
Characteristics
-
Solid
-
1.3±0.1 g/cm3
-
48°C
-
336.1°C at 760 mmHg
-
157.1±30.7 °C
-
1.506
-
1.50e+01 g/L
-
2-8°C
-
/It was/ reported that ifosfamide 80 mg/ml in sodium chloride 0.9% is chemically stable, exhibiting about a 7% loss in none days at 37 deg C in the dark. Ifosfamide 0.6 & 20 mg/ml in dextrose 5% in water, Ringer's injection. lactated, sodium chloride 0.9%, or sterile water for injection, polypropylene syringes, is physically & chemically stable for at least 24 hr at 30 deg C. Constitution to an ifosfamide concn of 100 mg/ml with benzyl alcohol-preserved bacteriostatic water for injection resulte
Safety Information
-
Ⅲ
-
6.1(b)
-
2934999090
-
3249
-
3
-
25-36
-
26-45
-
RP6050000
-
T
-
Missing Phrase - N15.00950417-P305 + P351 + P338
-
H301-H319
-
LD50 in rats (mg/kg): 160 i.p. (Arnold, 1973); also reported as 150 i.p. (Brock)
China Isophosphamide Export Data
Data referenced from General Administration of Customs,P.R.China
2018.11-2019.11 China - America Isophosphamide Export Data
From 2018.11 to 2019.11, total export volume of Isophosphamide from China to America was 7,780,901KG while total export value was $316,380,773. The biggest proportion of exporting volume in the last 12 months was 14.00% in 2019.01.
2018.11-2019.11 China Isophosphamide Export Data
From 2018.11 to 2019.11, total export volume of Isophosphamide from China was 64,534,318KG while total export value was $1,953,812,763. The biggest proportion of exporting volume in the last 12 months was 11.30% in 2019.03.
2018.11-2019.11 TOP10 Purchasing Countries' Export Data of Chinese Isophosphamide
From 2018.11 to 2019.11, China has exported Isophosphamide to 122 countries in total. Country ranks by import volume from high to low is India, America, Brazil, Korea, Japan, Indonesia, Russia, Italy, Vietnam, Germany. The highest export volume was China to India, accounting for 15.49% of the total volume of China.
Check Export Data for More Purchasing Countries
Purchasing Country | Export Volume(KG) | Export Percentage | Export Value($) |
---|---|---|---|
India |
18,470,088 |
15.49% |
284,654,978 |
America |
7,780,901 |
6.52% |
316,380,773 |
Brazil |
3,482,706 |
2.92% |
56,330,619 |
Korea |
3,279,208 |
2.75% |
118,103,066 |
Japan |
2,776,083 |
2.33% |
104,179,065 |
Indonesia |
2,652,708 |
2.22% |
20,390,824 |
Russia |
2,523,632 |
2.12% |
71,402,429 |
Italy |
1,949,908 |
1.64% |
84,261,295 |
Vietnam |
1,535,844 |
1.29% |
30,876,165 |
Germany |
1,414,521 |
1.19% |
66,834,261 |
Netherlands |
1,407,723 |
1.18% |
40,043,364 |
Taiwan |
1,336,285 |
1.12% |
20,935,258 |
Belgium |
1,300,937 |
1.09% |
43,926,617 |
Mexico |
1,203,788 |
1.01% |
45,215,734 |
Pakistan |
1,101,382 |
0.92% |
39,507,765 |
Iran |
1,044,291 |
0.88% |
28,504,479 |
Turkey |
905,770 |
0.76% |
27,893,056 |
Singapore |
780,141 |
0.65% |
50,171,634 |
Thailand |
719,956 |
0.60% |
8,501,101 |
Australia |
607,935 |
0.51% |
14,879,125 |
Israel |
588,856 |
0.49% |
17,159,090 |
South Africa |
575,310 |
0.48% |
11,039,850 |
United Kingdom |
501,238 |
0.42% |
39,994,256 |
Malaysia |
492,812 |
0.41% |
5,439,297 |
Spain |
446,770 |
0.37% |
28,670,245 |
United Arab Emirates |
304,282 |
0.26% |
3,897,959 |
Canada |
302,332 |
0.25% |
21,196,696 |
Colombia |
267,830 |
0.22% |
8,161,669 |
Poland |
267,574 |
0.22% |
13,242,033 |
Slovenia |
248,588 |
0.21% |
18,698,953 |
Latest News on Isophosphamide
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2